Marriage Counselors in Pikesville, MD Accepting Medicare

4 Marriage Counselors found. Showing 1 - 4

Merrilee Peske, LMFT Marriage & Family Therapist Medicare: Medicare Enrolled Practice Location: 104 Church Ln Ste 101, Pikesville, MD 21208 Phone: 410-343-9756

Krista Zerby, LGMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1829 Reisterstown Rd Ste 350322, Pikesville, MD 21208 Phone: 301-490-1011

Diamond Greene, LCMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 12 Estates Ct, Pikesville, MD 21208 Phone: 443-827-3124

Mrs. Shuranda Thephani Allen, PH.D Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1314 Bedford Ave, Suite 113, Pikesville, MD 21208 Phone: 410-493-7427

News Archive

Neurocrine Biosciences announces GSK561679 antagonist's efficacy in major depressive disorder

Neurocrine Biosciences, Inc. today announced top-line efficacy and safety results from a Phase II clinical trial utilizing Corticotropin Releasing Factor (CRF1) receptor antagonist GSK561679 in patients currently experiencing a major depressive episode.

Moderate therapeutic hypothermia does not improve neurological outcomes after cardiac arrest

In patients receiving therapeutic hypothermia after suffering out-of-hospital cardiac arrest, those who were cooled below 31 degrees Celsius (about 88 degrees Fahrenheit) for 24 hours showed no difference in terms of death or poor neurological outcomes at six months compared with patients receiving guideline-recommended cooling of 34 C (about 93 F).

Lower mortality rates in patients who visit the same doctor each time, study shows

A new study has found that patients who see a single doctor over the course of time and thus experience continuity of care, are less likely to die than those whose healthcare providers change repeatedly.

People who develop depression, MCI after age 65 are more vulnerable for accelerated brain aging

People who develop depression and mild cognitive impairment (MCI) after age 65 are more likely to have biological and brain imaging markers that reflect a greater vulnerability for accelerated brain aging, according to a study conducted by researchers at the University of Pittsburgh School of Medicine. The findings were published online in Molecular Psychiatry.

Cell Therapeutics announces preliminary results of phase II OPAXIO study for high-grade gliomas

Cell Therapeutics, Inc. announced the preliminary results of a phase II study of paclitaxel poliglumex (OPAXIO) combined with temozolomide (TMZ) and radiotherapy (RT) in patients with newly diagnosed high-grade gliomas.

Read more Medical News

› Verified 6 days ago